Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Halabi, Susan"'
Publikováno v:
Cancer, vol 120, iss 1
BackgroundThe current study was conducted to investigate the dependence between progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) and to explore whether PFS can be used as an intermediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d68a7b652734ed6424acad6804ab10d8
https://escholarship.org/uc/item/7652n3vw
https://escholarship.org/uc/item/7652n3vw
Autor:
Aggarwal, Rahul, Halabi, Susan, Kelly, William Kevin, George, Daniel, Mahoney, John F, Millard, Frederick, Stadler, Walter M, Morris, Michael J, Kantoff, Philip, Monk, J Paul, Carducci, Michael, Small, Eric J, Alliance for Clinical Trials in Oncology
Publikováno v:
Cancer, vol 119, iss 20
BackgroundPreliminary data suggest a potential decreased benefit of docetaxel in patients with metastatic, castration-resistant prostate cancer (mCRPC) who previously received abiraterone acetate, a novel androgen synthesis inhibitor (ASI). Cancer an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::af0fe86e457be39148c2f3d5cf9a6e82
https://escholarship.org/uc/item/28d6p66f
https://escholarship.org/uc/item/28d6p66f
Autor:
Apolo, Andrea B, Ostrovnaya, Irina, Halabi, Susan, Iasonos, Alexia, Philips, George K, Rosenberg, Jonathan E, Riches, Jamie, Small, Eric J, Milowsky, Matthew I, Bajorin, Dean F
Publikováno v:
Journal of the National Cancer Institute, vol 105, iss 7
A prognostic model that predicts overall survival (OS) for metastatic urothelial cancer (MetUC) patients treated with cisplatin-based chemotherapy was developed, validated, and compared with a commonly used Memorial Sloan-Kettering Cancer Center (MSK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::e32f6fdfe44c1656c36432154db32070
https://escholarship.org/uc/item/2nz9d4z5
https://escholarship.org/uc/item/2nz9d4z5